Characteristic | Value |
Age (IQR) (years) | 46 (40–53) |
FIGO stage | |
IA2 | 62 (1.2%) |
IB1 | 2482 (47.9%) |
IB2 | 388 (7.5%) |
IIA1 | 1598 (30.8%) |
IIA2 | 651 (12.6%) |
Histopathologic type | |
Squamous cell carcinoma | 4510 (87.0%) |
Adenocarcinoma | 488 (9.4%) |
Adenosquamous carcinoma | 183 (3.5%) |
Type of surgery | |
Radical hysterectomy | 4985 (96.2%) |
Modified hysterectomy | 54 (1.0%) |
Radical trachelectomy | 142 (2.7%) |
Para-aortic lymph node dissection | |
No | 4432 (85.5%) |
Yes | 749 (14.5%) |
Para-aortic lymph node metastasis | |
No | 640 (85.4%) |
Yes | 109 (14.6%) |
Ovarian conservation | |
No | 3685 (71.1%) |
Yes | 1496 (28.9%) |
Ovarian metastasis | |
No | 3645 (98.9%) |
Yes | 40 (1.1%) |
Adjuvant treatment | |
No | 1714 (35.5%) |
Chemotherapy | 535 (11.1%) |
Radiotherapy | 929 (19.3%) |
Concurrent chemoradiotherapy | 1646 (34.1%) |
FIGO, International Federation of Gynecology and Obstetrics; IQR, interquartile range.